Reduced thalamic volume in patients with chronic schizophrenia after switching from typical antipsychotic medications to olanzapine. [electronic resource]
Producer: 20070110Description: 2005-7 p. digitalISSN:- 0002-953X
- Adult
- Antipsychotic Agents -- adverse effects
- Atrophy
- Benzodiazepines -- adverse effects
- Chlorpromazine -- adverse effects
- Chronic Disease
- Female
- Follow-Up Studies
- Humans
- Hypertrophy
- Longitudinal Studies
- Magnetic Resonance Imaging
- Male
- Olanzapine
- Schizophrenia -- drug therapy
- Thalamus -- drug effects
- Therapeutic Equivalency
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.